Alcohol, Other Drugs, and the Liver

Editorials1 November 1968Alcohol, Other Drugs, and the LiverEMANUEL RUBIN, M.D., CHARLES S. LIEBER, M.D.EMANUEL RUBIN, M.D., CHARLES S. LIEBER, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-69-5-1063 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDuring the last decade numerous biochemical and ultrastructural studies have greatly expanded our understanding of the mechanisms involved in drug metabolism. Comprehensive recent reviews of this subject include those of Conney (1), Remmer (2), and Gillette (3). Most exogenous substances—such as pharmacologic agents, carcinogens, and insecticides—are detoxified by enzyme systems located in the microsomal fraction of the liver cell, which corresponds to the membranes of the endoplasmic reticulum seen with the electron microscope. Detoxification generally involves conversion of the molecule to a more polar form, thus rendering lipid soluble materials more water soluble for urinary excretion. This is usually accomplished...References1. CONNEY AH: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19: 317, 1967. MedlineGoogle Scholar2. REMMER H: Induction of drug metabolizing enzymes in the endoplasmic reticulum of the liver by treatment with drugs. German Med. Monthly 13: 53, 1968. MedlineGoogle Scholar3. GILLETTE JR: Biochemistry of drug oxidation and reduction by enzymes in hepatic endoplasmic reticulum, in Advances in Pharmacology, vol. 4, edited by GARRATTINI, S., SHORE, P. A., Academic Press Inc., Publishers, New York, 1965, pp. 219-261. Google Scholar4. CUCINELLCONNEYSANSURBURNS SAAHMJJ: Drug interactions in man. 1. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicumarol) and diphenylhydantoin (Dilantin). Clin. Pharmacol. Therap. 6: 420, 1965. CrossrefMedlineGoogle Scholar5. GOSSDICKHAUS JEDW: Increased bishydroxycoumarin requirements in patients receiving phenobarbital. New Eng. J. Med. 273: 1094, 1965. CrossrefMedlineGoogle Scholar6. CUCINELLODESSKYWEISSDAYTON SALMPG: The effect of chloral hydrate on bishydroxycoumarin metabolism; a fatal outcome. JAMA 197: 366, 1966. CrossrefMedlineGoogle Scholar7. BUSFIELDCHILDATKINSONTOMICH DKJRMEG: An effect of phenobarbitone on blood-levels of griseofulvin in man. Lancet 2: 1042, 1963. CrossrefMedlineGoogle Scholar8. JELLIFFEBLANKENHORN RWDH: Effect of phenobarbital on digitoxin metabolism (abstract). Clin. Res. 14: 160, 1966. Google Scholar9. CONNEYKLUTCH AHA: Stimulatory effect of drugs on liver microsomal enzymes that metabolize steroids and drugs. Fed. Proc. 21: 182, 1962. Google Scholar10. KUNTZMANJACOBSONSCHNEIDMANCONNEY RMKAH: Similarities between oxidative drug-metabolizing enzymes and steroid hydroxylases in liver microsomes. J. Pharmacol. Exp. Therap. 146: 280, 1964. MedlineGoogle Scholar11. CONNEYJACOBSONLEVINSCHEIDMANKUNTZMAN AHMWKR: Decreased central depressant effect of progesterone and other steroids in rats pretreated with drugs and insecticides. J. Pharmacol. Exp. Therap. 154: 310, 1966. MedlineGoogle Scholar12. LEVINWELCHCONNEY WRMAH: Decreased uterotropic potency of oral contraceptives in rats pretreated with phenobarbital. Endocrinology 83: 149, 1968. CrossrefMedlineGoogle Scholar13. CONNEYMILLERMILLER AHECJA: The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res. 16: 450, 1956. MedlineGoogle Scholar14. MILLERMILLERBROWNMACDONALD ECJARRJC: On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene. Cancer Res. 18: 460, 1958. Google Scholar15. KOCZOCIK-PRZEDPELSKA J: Effect of stimulation and sedation on the development of experimental neoplasms. Acta Physiol. Pol. 8: 709, 1957. MedlineGoogle Scholar16. WERKSHOLTONOLINGER EELJCP: Amelioration of non-tumorous Cushing's syndrome by diphenylhydantoin (abstract). Program of the Second International Congress of Hormonal Steroids, Milan, 1966. Google Scholar17. YAFFELEVYMATSUZAWABALIAH SJGTT: Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. New Eng. J. Med. 275: 1461, 1966. CrossrefMedlineGoogle Scholar18. THOMPSONWILLIAMS RPR: Treatment of chronic intrahepatic cholestasis with phenobarbitone. Lancet 2: 646, 1967. CrossrefMedlineGoogle Scholar19. MAURERWOLFFFINSTERPOPPERSPANTUCKKUNTZMANCONNEY HMJAMPJERAH: Reduction in concentration of total serum-bilirubin in offspring of women treated with phenobarbitone during pregnancy. Lancet 2: 122, 1968. CrossrefMedlineGoogle Scholar20. SOEHRINGSCHUPPEL KR: Wechselwirkungen zwischen Alkohol und Arzneimitteln. Deutsch Med. Woschr. 91: 1892, 1966. CrossrefMedlineGoogle Scholar21. ISERILIEBERGOTTLIEB OACSLS: The ultrastructure of fatty liver induced by prolonged ethanol ingestion. Amer. J. Path. 48: 535, 1966. MedlineGoogle Scholar22. RUBINLIEBER ECS: Alcohol induced hepatic injury in nonalcoholic volunteers. New Eng. J. Med. 278: 869, 1968. CrossrefMedlineGoogle Scholar23. HARTROFTPORTA WSEA: Alcohol, diet, and experimental hepatic injury. Canad. J. Physiol. Pharmacol. 46: 463, 1968. CrossrefMedlineGoogle Scholar24. LIEBER CS: Metabolic derangement induced by alcohol. Ann. Rev. Med. 18: 35, 1967. CrossrefMedlineGoogle Scholar25. RUBINHUTTERERLIEBER EFCS: Ethanol increases hepatic smooth endoplasmic reticulum and drug-metabolizing enzymes. Science 159: 1469, 1968. CrossrefMedlineGoogle Scholar26. LIEBERRUBIN CSE: Ethanol—a hepatotoxic drug. Gastroenterology 54: 642, 1968. CrossrefMedlineGoogle Scholar27. RUBINLIEBER ECS: Hepatic microsomal enzymes in man and rat: induction and inhibition by ethanol. Science: in press, 1968. CrossrefGoogle Scholar28. LIEBERDECARLI CSLM: Effect of ethanol on cholesterol metabolism (abstract). Clin. Res. 12: 274, 1964. Google Scholar29. LIEBERDECARLI CSLM: Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science: in press, 1968. CrossrefGoogle Scholar30. FISCHER HD: Der Einfluss von Barbituraten auf die Entgiftungsgeschwindigkeit des Äthanols. Biochem. Pharmacol. 11: 307, 1962. CrossrefMedlineGoogle Scholar31. CROUSEGERSONDECARLILIEBER JRCDLCS: Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. J. Lipid Res. 9: 509, 1968. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byMACROPHAGES v. CANCERENHANCEMENT OF BILIRUBIN CLEARANCE AND HEPATIC HÆM TURNOVER BY ETHANOLDrug InteractionsThe Effect of Physical Environmental Factors on Drug ResponseCNS Drugs Analgesics and AntipyreticsTHE PROGRAM AT MOUNT SINAI SCHOOL OF MEDICINE AND IMPLICATIONS FOR TEACHING ALCOHOLIC LIVER DISEASEAlcohol and the liver.Ethanol binding to hepatic microsomes—its increase by ethanol consumptionInhibition of drug metabolism by acute ethanol intoxicationImmunologische Ph�nomene bei Leberkrankheiten: Die Bedeutung mitochondrialer Antik�rperA TEST FOR ALCOHOLISM?ETHANOL AND NEONATAL BILIRUBIN LEVELS 1 November 1968Volume 69, Issue 5Page: 1063-1067KeywordsCarcinogensCell membranesDetoxificationDrug metabolismDrugsElectron microscopyEnzymesExcretionLipidsLiver Issue Published: 1 November 1968 PDF downloadLoading ...